Cargando…
Progression Risk Score Estimation Based on Immunostaining Data in Oral Cancer Using Unsupervised Hierarchical Clustering Analysis: A Retrospective Study in Taiwan
This study aimed to investigate whether the progression risk score (PRS) developed from cytoplasmic immunohistochemistry (IHC) biomarkers is available and applicable for assessing risk and prognosis in oral cancer patients. Participants in this retrospective case-control study were diagnosed between...
Autores principales: | Wang, Hui-Ching, Chan, Leong-Perng, Wu, Chun-Chieh, Hsiao, Hui-Hua, Liu, Yi-Chang, Cho, Shih-Feng, Du, Jeng-Shiun, Liu, Ta-Chih, Yang, Cheng-Hong, Pan, Mei-Ren, Moi, Sin-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466609/ https://www.ncbi.nlm.nih.gov/pubmed/34575686 http://dx.doi.org/10.3390/jpm11090908 |
Ejemplares similares
-
Application of the Interaction between Tissue Immunohistochemistry Staining and Clinicopathological Factors for Evaluating the Risk of Oral Cancer Progression by Hierarchical Clustering Analysis: A Case-Control Study in a Taiwanese Population
por: Wang, Hui-Ching, et al.
Publicado: (2021) -
The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy
por: Wang, Hui-Ching, et al.
Publicado: (2023) -
Effect of Tumor Microenvironment and Angiogenesis on Clinical Outcomes of Primary Central Nervous System Lymphoma
por: Wang, Hui-Ching, et al.
Publicado: (2021) -
Clustering of Chromatin Remodeling Enzymes Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Pancreatic Cancer
por: Wang, Hui-Ching, et al.
Publicado: (2022) -
Silencing DNA Polymerase β Induces Aneuploidy as a Biomarker of Poor Prognosis in Oral Squamous Cell Cancer
por: Wang, Hui-Ching, et al.
Publicado: (2021)